PYXS
Pyxis Oncology Inc
3.40$
+2.1%
vs. previous close
Closing price · As of: Sep 17, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Pyxis Oncology Inc (PYXS) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/09/2026 | Current report (8-K) | Pyxis Oncology, Inc. (PYXS): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View report ↗ |
| 09/08/2026 | Current report (8-K) | Pyxis Oncology, Inc. (PYXS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 08/13/2026 | Current report (8-K) | Pyxis Oncology, Inc. (PYXS): Results of Operations and Financial Condition | View report ↗ |
| 07/10/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.